Can we select the right patient for immunotherapy in NSCLC? The pathologist’s point of view

Date 10 October 2016
Event ESMO 2016 Congress
Session The earthquake of immunotherapy in lung cancer
Topics Non-Small-Cell Lung Cancer, Metastatic
Immunotherapy
Pathology/Molecular Biology
Presenter Ming Tsao
Authors M. Tsao
  • Pathology, Princess Margaret Cancer Centre, M5G 1L7 - Toronto, ON/CA